Vertex Pharmaceuticals Incorporated Prepares for (More) Growth

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 2 August, 2016 by The TZ Newswire Staff

Vertex Pharmaceuticals Incorporated Prepares for (More) Growth

Image source: Getty Images.

Vertex Pharmaceuticals (NASDAQ: VRTX) reported second-quarter earnings last week as the company continues to grow sales of its cystic fibrosis franchise.

See also
- Next Article MAS Launches International FinTech Advisory Panel
- Previous Article Ford’s stock plunges as ‘car recession’ bleeds into July
Editorial Calender

August 2016

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

« Jul Sep »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 2 August, 2016 by The TZ Newswire Staff

Vertex Pharmaceuticals Incorporated Prepares for (More) Growth

See also

Editorial Calender

Recent Tags